SEC Filings TLDR

A Schedule 13G filing was submitted by Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Securities GP LLC, and Kenneth Griffin regarding their ownership in FG Nexus Inc. The filing indicates that Citadel Advisors LLC, Citadel Advisors Holdi...

Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin have jointly filed a Schedule 13G with the SEC regarding their ownership of shares in Etsy, Inc. The filing indicates that Citadel Securities LLC benefi...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 5.3% of the common stock of Dianthus Therapeutics, Inc. The filing indicates that Point72 Asset Management maintains investment and voting power ov...

Hensley & Company has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 6,180,554 shares of Series A Preferred stock in CISO Global, Inc., representing 66% of the class. The filing indicates that Hensley & Company has sole voting and dispositive power over these shares. The filing is made pursua...

Clark Jermoluk Founders Fund I LLC and James H. Clark have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of Class A common stock of Ibotta, Inc. The filing indicates that Fund I directly holds 3,841,308 shares of Class A common stock, representing approximately 15.2% of the outstanding shares...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 9.8% of the common stock of FG Nexus Inc. The filing, dated September 11, 2025, indicates that the shares are held by Point72 Associates, LLC, an i...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing a 9.8% beneficial ownership in FG Nexus Inc. The filing indicates that Point72 Asset Management maintains investment and voting power over the shares held by Point72 Associates,...

L1 Capital Global Opportunities Master Fund, Ltd. has reported a 9.99% beneficial ownership in Youxin Technology Ltd, as per the Schedule 13G filing. The fund holds 4,638,200 Class A Ordinary Shares and Series A Warrants, which are subject to a 9.99% beneficial ownership limitation. The filing indicates that the shares...

Sculptor Capital LP, along with its subsidiaries and affiliates, has filed a Schedule 13G indicating a 5.19% ownership in Sotera Health Company. The filing reports that Sculptor Capital LP and Sculptor Capital II LP collectively manage 14,750,000 common shares of Sotera Health Company. The shares are held in accounts m...

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 7.7% of the common stock of KALA BIO, Inc. The filing indicates that the Master Fund directly holds 543,745 shares of Common Stock. Perceptive Advisors...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G indicating a 6.7% ownership stake in KALA BIO, Inc. The filing, dated September 11, 2025, reports that Point72 Asset Management maintains investment and voting power over the shares held by Point72 Asso...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing a 9.8% beneficial ownership in FG Nexus Inc. The filing indicates that Point72 Asset Management maintains investment and voting power over the shares held by Point72 Associates,...

Stephanie Foglia, a United States citizen, filed a Schedule 13G with the SEC, disclosing beneficial ownership of 5.1% of Mistras Group, Inc.'s common stock, amounting to 1,600,046 shares. The filing indicates that the shares are held solely by Foglia, with no shared voting or dispositive power. The filing is made under...

Kristy Kyriakopoulos has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 1,669,553 shares of Mistras Group, Inc., representing 5.3% of the outstanding shares. The filing indicates that the shares are held solely by Kyriakopoulos, with no shared voting or dispositive power. The filing is made under...

Aspasia Vahaviolos, a United States citizen, has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 6,105,650 shares of common stock in Mistras Group, Inc., representing 19.4% of the outstanding shares as of August 6, 2025. The filing indicates that Vahaviolos has sole voting and dispositive power ov...

Ameriprise Financial, Inc. (AFI) and Columbia Management Investment Advisers, LLC (CMIA) have filed a Schedule 13G with the SEC regarding their beneficial ownership of shares in Columbia Credit Income Opportunities Fund. As of June 30, 2025, AFI and CMIA collectively own 2,499,500 Class A shares, representing 96.4% of ...

Permit Capital, LLC, Permit Capital Enterprise Fund, LP, Permit Capital GP, LP, and John C. Broderick have filed a Schedule 13G with the SEC regarding their ownership in QVC Group, Inc. Permit Capital, LLC holds 4.6% of the Series A Common Stock, amounting to 361,790 shares. Permit Capital Enterprise Fund, LP also hold...

This Schedule 13G filing is submitted by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, collectively referred to as the Reporting Persons. The filing discloses their beneficial ownership of 9.99% of Purple Biotech Ltd.'s ordinary shares, totaling 139,632,475 shares. The shares include those held dire...

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G indicating beneficial ownership of 7.07% of ZimVie Inc.'s common stock, totaling 1,994,479 shares. The filing, made under Rule 13d-1(c), states that the shares are held by funds and managed accounts for which Glazer Capital serves as investment manager. T...

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G indicating their ownership in scPharmaceuticals Inc. As of the filing date, Glazer Capital and Paul J. Glazer collectively own 2,474,820 shares of common stock, representing 4.64% of the outstanding shares. The filing states that the shares are held by ce...

Viking Global Investors LP and its affiliates have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of Saia Inc. common stock. The filing includes Viking Global Performance LLC, Viking Global Equities II LP, Viking Global Equities Master Ltd., Viking Long Fund GP LLC, Viking Long Fund Master Ltd...

Permit Capital, LLC, Permit Capital Enterprise Fund, LP, Permit Capital GP, LP, and John C. Broderick have filed a Schedule 13G regarding their ownership in QVC Group, Inc.'s Series A Common Stock. Permit Capital, LLC, an investment advisor, manages funds that hold 361,790 shares (4.6% of the outstanding shares). Permi...

Permit Capital, LLC, Permit Capital Enterprise Fund, LP, Permit Capital GP, LP, and John C. Broderick have filed a Schedule 13G disclosing their ownership in QVC Group, Inc. Permit Capital, LLC owns 4.6% of the Series A Common Stock, representing 361,790 shares. Permit Capital Enterprise Fund, LP and Permit Capital GP,...

A Schedule 13G filing was submitted by Westbourne River Event Master Fund (WREMF), Tetragon Financial Group Limited, TFG Asset Management L.P., and other related entities, reporting beneficial ownership of common shares in Kolibri Global Energy Inc. The filing indicates that WREMF, a Cayman Islands exempted company, di...

This Schedule 13G filing, submitted by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, discloses their beneficial ownership of 7.7% of Aethlon Medical, Inc.'s common stock. The filing details the ownership structure following the execution of a Securities Purchase Agreement on September 4, 2025, which...